{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:10:11Z","timestamp":1793052611254,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00210-025-04166-z","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T05:32:53Z","timestamp":1745213573000},"page":"14009-14024","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Conjugation of hydrazine to PEGylated silica-coated magnetite nanoparticles as pH-responsive magnetic nanocarriers for covalent loading and controlled release of doxorubicin"],"prefix":"10.1007","volume":"398","author":[{"given":"Seyed Masih Abtahi","family":"Naeini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Faramarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Heydarinasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"4166_CR1","doi-asserted-by":"publisher","first-page":"2404391","DOI":"10.1002\/adhm.202404391","volume":"14","author":"C Caro","year":"2025","unstructured":"Caro C, Paez-Mu\u00f1oz JM, Pern\u00eda Leal M et al (2025) Metabolically-driven active targeting of magnetic nanoparticles functionalized with glucuronic acid to glioblastoma: application to MRI-tracked magnetic hyperthermia therapy. Adv Healthc Mater 14:2404391. https:\/\/doi.org\/10.1002\/adhm.202404391","journal-title":"Adv Healthc Mater"},{"key":"4166_CR2","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10311-018-00841-1","volume":"17","author":"M Chamundeeswari","year":"2019","unstructured":"Chamundeeswari M, Jeslin J, Verma ML (2019) Nanocarriers for drug delivery applications. Environ Chem Lett 17:849\u2013865. https:\/\/doi.org\/10.1007\/s10311-018-00841-1","journal-title":"Environ Chem Lett"},{"key":"4166_CR3","doi-asserted-by":"publisher","first-page":"9594","DOI":"10.1039\/c2jm16792a","volume":"22","author":"Y Chang","year":"2012","unstructured":"Chang Y, Liu N, Chen L et al (2012) Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery. J Mater Chem 22:9594\u20139601. https:\/\/doi.org\/10.1039\/c2jm16792a","journal-title":"J Mater Chem"},{"key":"4166_CR4","doi-asserted-by":"publisher","first-page":"109939","DOI":"10.1016\/j.msec.2019.109939","volume":"104","author":"L Chen","year":"2019","unstructured":"Chen L, Zheng J, Du J et al (2019) Folic acid-conjugated magnetic ordered mesoporous carbon nanospheres for doxorubicin targeting delivery. Mater Sci Eng C 104:109939. https:\/\/doi.org\/10.1016\/j.msec.2019.109939","journal-title":"Mater Sci Eng C"},{"key":"4166_CR5","doi-asserted-by":"publisher","first-page":"112311","DOI":"10.1016\/j.msec.2021.112311","volume":"128","author":"BS Dash","year":"2021","unstructured":"Dash BS, Lu Y-J, Chen H-A et al (2021) Magnetic and GRPR-targeted reduced graphene oxide\/doxorubicin nanocomposite for dual-targeted chemo-photothermal cancer therapy. Mater Sci Eng C 128:112311. https:\/\/doi.org\/10.1016\/j.msec.2021.112311","journal-title":"Mater Sci Eng C"},{"key":"4166_CR6","doi-asserted-by":"publisher","first-page":"212764","DOI":"10.1016\/j.bioadv.2022.212764","volume":"136","author":"BS Dash","year":"2022","unstructured":"Dash BS, Lu Y-J, Pejrprim P et al (2022) Hyaluronic acid-modified, IR780-conjugated and doxorubicin-loaded reduced graphene oxide for targeted cancer chemo\/photothermal\/photodynamic therapy. Biomater Adv 136:212764. https:\/\/doi.org\/10.1016\/j.bioadv.2022.212764","journal-title":"Biomater Adv"},{"key":"4166_CR7","doi-asserted-by":"publisher","first-page":"129401","DOI":"10.1016\/j.ijbiomac.2024.129401","volume":"260","author":"BS Dash","year":"2024","unstructured":"Dash BS, Lu Y-J, Huang Y-S, Chen J-P (2024) Chitosan-coated magnetic graphene oxide for targeted delivery of doxorubicin as a nanomedicine approach to treat glioblastoma. Int J Biol Macromol 260:129401. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129401","journal-title":"Int J Biol Macromol"},{"key":"4166_CR8","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1038\/s41598-024-54778-3","volume":"14","author":"M Deinavizadeh","year":"2024","unstructured":"Deinavizadeh M, Kiasat AR, Shafiei M et al (2024) Synergistic chemo-photothermal therapy using gold nanorods supported on thiol-functionalized mesoporous silica for lung cancer treatment. Sci Rep 14:4373. https:\/\/doi.org\/10.1038\/s41598-024-54778-3","journal-title":"Sci Rep"},{"key":"4166_CR9","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/bm501290t","volume":"15","author":"H Deng","year":"2014","unstructured":"Deng H, Liu J, Zhao X et al (2014) PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin. Biomacromol 15:4281\u20134292. https:\/\/doi.org\/10.1021\/bm501290t","journal-title":"Biomacromol"},{"key":"4166_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbrc.2017.06.190","volume":"500","author":"F Edlich","year":"2018","unstructured":"Edlich F (2018) BCL-2 proteins and apoptosis: recent insights and unknowns. Biochem Biophys Res Commun 500:26\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.190","journal-title":"Biochem Biophys Res Commun"},{"key":"4166_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","volume":"5","author":"K Elumalai","year":"2024","unstructured":"Elumalai K, Srinivasan S, Shanmugam A (2024) Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomed Technol 5:109\u2013122","journal-title":"Biomed Technol"},{"key":"4166_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijpharm.2016.03.022","volume":"504","author":"F Farjadian","year":"2016","unstructured":"Farjadian F, Ghasemi S, Mohammadi-Samani S (2016) Hydroxyl-modified magnetite nanoparticles as novel carrier for delivery of methotrexate. Int J Pharm 504:110\u2013116. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.022","journal-title":"Int J Pharm"},{"key":"4166_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s13233-021-9007-6","volume":"29","author":"J Farzanfar","year":"2021","unstructured":"Farzanfar J, Farjadian F, Roointan A et al (2021) Assessment of pH responsive delivery of methotrexate based on PHEMA-st-PEG-DA nanohydrogels. Macromol Res 29:54\u201361. https:\/\/doi.org\/10.1007\/s13233-021-9007-6","journal-title":"Macromol Res"},{"key":"4166_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ijpharm.2013.06.020","volume":"453","author":"R Ferrari","year":"2013","unstructured":"Ferrari R, Colombo C, Casali C et al (2013) Synthesis of surfactant free PCL\u2013PEG brushed nanoparticles with tunable degradation kinetics. Int J Pharm 453:551\u2013559. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.06.020","journal-title":"Int J Pharm"},{"key":"4166_CR15","doi-asserted-by":"publisher","first-page":"120907","DOI":"10.1016\/j.carbpol.2023.120907","volume":"314","author":"F He","year":"2023","unstructured":"He F, Xie C, Xu X (2023) Hyaluronic acid-modified yeast \u03b2-glucan particles delivering doxorubicin for treatment of breast cancer. Carbohydr Polym 314:120907. https:\/\/doi.org\/10.1016\/j.carbpol.2023.120907","journal-title":"Carbohydr Polym"},{"key":"4166_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.msec.2016.05.036","volume":"67","author":"A Heidarinasab","year":"2016","unstructured":"Heidarinasab A, Ahmad Panahi H, Faramarzi M, Farjadian F (2016) Synthesis of thermosensitive magnetic nanocarrier for controlled sorafenib delivery. Mater Sci Eng C 67:42\u201350. https:\/\/doi.org\/10.1016\/j.msec.2016.05.036","journal-title":"Mater Sci Eng C"},{"key":"4166_CR17","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1002\/adfm.201504185","volume":"26","author":"J Huang","year":"2016","unstructured":"Huang J, Li Y, Orza A et al (2016) Magnetic nanoparticle facilitated drug delivery for cancer therapy with targeted and image-guided approaches. Adv Funct Mater 26:3818\u20133836. https:\/\/doi.org\/10.1002\/adfm.201504185","journal-title":"Adv Funct Mater"},{"key":"4166_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-025-01836-6","author":"Y-H Huang","year":"2025","unstructured":"Huang Y-H, Sivakumar G, Kamaraj R et al (2025) Combination of mannoside and phenylboronic acid polycaprolactone polymers for doxorubicin-encapsulated polymersome nanomedicine targeting MDA-MB-231 cancer cells. Drug Deliv Transl Res. https:\/\/doi.org\/10.1007\/s13346-025-01836-6","journal-title":"Drug Deliv Transl Res"},{"key":"4166_CR19","doi-asserted-by":"publisher","first-page":"126862","DOI":"10.1016\/j.matchemphys.2022.126862","volume":"293","author":"FM Jadval Ghadam","year":"2022","unstructured":"Jadval Ghadam FM, Faramarzi M, Panahi HA, Mousavi Parsa SA (2022) Glucuronic acid-conjugated smart cellulose nanocrystals as novel carrier for gemcitabine delivery. Mater Chem Phys 293:126862. https:\/\/doi.org\/10.1016\/j.matchemphys.2022.126862","journal-title":"Mater Chem Phys"},{"key":"4166_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00289-021-03537-9","author":"S Jafari","year":"2021","unstructured":"Jafari S, Soleimani M, Badinezhad M (2021) Application of different mathematical models for further investigation of in vitro drug release mechanisms based on magnetic nano - composite. Polymer Bullet. https:\/\/doi.org\/10.1007\/s00289-021-03537-9","journal-title":"Polymer Bullet"},{"key":"4166_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.biomaterials.2016.01.061","volume":"85","author":"M Kanamala","year":"2016","unstructured":"Kanamala M, Wilson WR, Yang M et al (2016) Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review. Biomaterials 85:152\u2013167. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.01.061","journal-title":"Biomaterials"},{"key":"4166_CR22","doi-asserted-by":"publisher","first-page":"127205","DOI":"10.1016\/j.colsurfa.2021.127205","volume":"627","author":"S Karimi","year":"2021","unstructured":"Karimi S, Namazi H (2021) Synthesis of folic acid-conjugated glycodendrimer with magnetic \u03b2-cyclodextrin core as a pH-responsive system for tumor-targeted co-delivery of doxorubicin and curcumin. Colloids Surf A Physicochem Eng Asp 627:127205. https:\/\/doi.org\/10.1016\/j.colsurfa.2021.127205","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"4166_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.msec.2010.01.006","volume":"30","author":"S Kayal","year":"2010","unstructured":"Kayal S, Ramanujan RV (2010) Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery. Mater Sci Eng C 30:484\u2013490. https:\/\/doi.org\/10.1016\/j.msec.2010.01.006","journal-title":"Mater Sci Eng C"},{"key":"4166_CR24","doi-asserted-by":"publisher","first-page":"110366","DOI":"10.1016\/j.inoche.2022.110366","volume":"148","author":"H Khodayari","year":"2023","unstructured":"Khodayari H, Heydarinasab A, Moniri E, Miralinaghi M (2023) Synthesis and characterization of magnetic nanoparticles-grafted-hyaluronic acid\/\u03b2-cyclodextrin as a novel pH-sensetive nanocarrier for targeted delivery of doxorubicin. Inorg Chem Commun 148:110366. https:\/\/doi.org\/10.1016\/j.inoche.2022.110366","journal-title":"Inorg Chem Commun"},{"key":"4166_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jmmm.2014.09.044","volume":"375","author":"M Khoobi","year":"2015","unstructured":"Khoobi M, Delshad TM, Vosooghi M et al (2015) Polyethyleneimine-modified superparamagnetic Fe3O4 nanoparticles: an efficient, reusable and water tolerance nanocatalyst. J Magn Magn Mater 375:217\u2013226. https:\/\/doi.org\/10.1016\/j.jmmm.2014.09.044","journal-title":"J Magn Magn Mater"},{"key":"4166_CR26","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.1021\/acsabm.4c00999","volume":"7","author":"B Kruse","year":"2024","unstructured":"Kruse B, Dash BS, Kostka K et al (2024) Doxorubicin-loaded ultrasmall gold nanoparticles (1.5 nm) for brain tumor therapy and assessment of their biodistribution. ACS Appl Bio Mater 7:6890\u20136907. https:\/\/doi.org\/10.1021\/acsabm.4c00999","journal-title":"ACS Appl Bio Mater"},{"key":"4166_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ces.2014.08.046","volume":"125","author":"JH Lee","year":"2015","unstructured":"Lee JH, Yeo Y (2015) Controlled drug release from pharmaceutical nanocarriers. Chem Eng Sci 125:75\u201384. https:\/\/doi.org\/10.1016\/j.ces.2014.08.046","journal-title":"Chem Eng Sci"},{"key":"4166_CR28","doi-asserted-by":"publisher","first-page":"22954","DOI":"10.1039\/C7RA02447A","volume":"7","author":"J Li","year":"2017","unstructured":"Li J, Mao J, Tang J et al (2017) Surface spermidine functionalized PEGylated poly(lactide-co-glycolide) nanoparticles for tumor-targeted drug delivery. RSC Adv 7:22954\u201322963. https:\/\/doi.org\/10.1039\/C7RA02447A","journal-title":"RSC Adv"},{"key":"4166_CR29","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c22168","author":"K Ling","year":"2025","unstructured":"Ling K, Bu J, Huang W et al (2025) Robust Cu2+-modified black phosphorus nanoplatform for enhanced drug delivery and synergistic multimodal tumor therapy via metal ion-assisted \u03c0\u2013\u03c0 interactions. ACS Appl Mater Interfaces. https:\/\/doi.org\/10.1021\/acsami.4c22168","journal-title":"ACS Appl Mater Interfaces"},{"key":"4166_CR30","doi-asserted-by":"publisher","first-page":"114378","DOI":"10.1016\/j.inoche.2025.114378","volume":"177","author":"SE Mohammadi Mehr","year":"2025","unstructured":"Mohammadi Mehr SE, Faramarzi M, Parsa SAM (2025a) Synthesis and characterization of a new smart magnetic nanocarrier for drug delivery. Inorg Chem Commun 177:114378. https:\/\/doi.org\/10.1016\/j.inoche.2025.114378","journal-title":"Inorg Chem Commun"},{"key":"4166_CR31","doi-asserted-by":"publisher","first-page":"141288","DOI":"10.1016\/j.molstruc.2024.141288","volume":"1328","author":"SE Mohammadi Mehr","year":"2025","unstructured":"Mohammadi Mehr SE, Faramarzi M, Parsa SAM (2025b) Active-targeting pH\/temperature-responsive magnetic nanocarriers based on poly(N-isopropylacrylamide) and spermine-dendronized magnetite nanoparticles for controlled cyclophosphamide delivery. J Mol Struct 1328:141288. https:\/\/doi.org\/10.1016\/j.molstruc.2024.141288","journal-title":"J Mol Struct"},{"key":"4166_CR32","doi-asserted-by":"publisher","first-page":"138012","DOI":"10.1016\/j.molstruc.2024.138012","volume":"1307","author":"S Murugappan","year":"2024","unstructured":"Murugappan S, Dastari S, Jungare K et al (2024) Hydrazide-hydrazone\/hydrazone as enabling linkers in anti-cancer drug discovery: a comprehensive review. J Mol Struct 1307:138012. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138012","journal-title":"J Mol Struct"},{"key":"4166_CR33","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1039\/C5NR06756A","volume":"8","author":"R Prasad","year":"2016","unstructured":"Prasad R, Aiyer S, Chauhan DS et al (2016) Bioresponsive carbon nano-gated multifunctional mesoporous silica for cancer theranostics. Nanoscale 8:4537\u20134546. https:\/\/doi.org\/10.1039\/C5NR06756A","journal-title":"Nanoscale"},{"key":"4166_CR34","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1021\/acsabm.0c01478","volume":"4","author":"R Prasad","year":"2021","unstructured":"Prasad R, Jain NK, Yadav AS et al (2021) Ultrahigh penetration and retention of graphene quantum dot mesoporous silica nanohybrids for image guided tumor regression. ACS Appl Bio Mater 4:1693\u20131703. https:\/\/doi.org\/10.1021\/acsabm.0c01478","journal-title":"ACS Appl Bio Mater"},{"key":"4166_CR35","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/pharmaceutics15071872","volume":"15","author":"A Pusta","year":"2023","unstructured":"Pusta A, Tertis M, Cr\u0103ciunescu I et al (2023) Recent advances in the development of drug delivery applications of magnetic nanomaterials. Pharmaceutics 15:1872. https:\/\/doi.org\/10.3390\/pharmaceutics15071872","journal-title":"Pharmaceutics"},{"key":"4166_CR36","doi-asserted-by":"publisher","first-page":"108447","DOI":"10.1016\/j.mtcomm.2024.108447","volume":"38","author":"AR Rad","year":"2024","unstructured":"Rad AR, Faramarzi M, Heydarinasab A (2024) Functionalized PEGylated graphene oxide with folic acid and hydrazine as a new pH-responsive nanocarrier for doxorubicin delivery. Mater Today Commun 38:108447. https:\/\/doi.org\/10.1016\/j.mtcomm.2024.108447","journal-title":"Mater Today Commun"},{"key":"4166_CR37","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1080\/09205063.2018.1466470","volume":"29","author":"N Rahoui","year":"2018","unstructured":"Rahoui N, Jiang B, Taloub N et al (2018) Synthesis and evaluation of water soluble pH sensitive poly (vinyl alcohol)-doxorubicin conjugates. J Biomater Sci Polym Ed 29:1482\u20131497. https:\/\/doi.org\/10.1080\/09205063.2018.1466470","journal-title":"J Biomater Sci Polym Ed"},{"key":"4166_CR38","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s11010-023-04783-3","volume":"479","author":"Y Robert Li","year":"2024","unstructured":"Robert Li Y, Traore K, Zhu H (2024) Novel molecular mechanisms of doxorubicin cardiotoxicity: latest leading-edge advances and clinical implications. Mol Cell Biochem 479:1121\u20131132. https:\/\/doi.org\/10.1007\/s11010-023-04783-3","journal-title":"Mol Cell Biochem"},{"key":"4166_CR39","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/bph.12431","volume":"171","author":"MJ Roy","year":"2014","unstructured":"Roy MJ, Vom A, Czabotar PE, Lessene G (2014) Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway. Br J Pharmacol 171:1973\u20131987. https:\/\/doi.org\/10.1111\/bph.12431","journal-title":"Br J Pharmacol"},{"key":"4166_CR40","doi-asserted-by":"publisher","first-page":"105410","DOI":"10.1016\/j.reactfunctpolym.2022.105410","volume":"180","author":"M Safaviyan","year":"2022","unstructured":"Safaviyan M, Faramarzi M, Parsa SAM, Karimi H (2022) Tetraethylenepentamine-enriched magnetic graphene oxide as a novel Cr(VI) removal adsorbent. React Funct Polym 180:105410. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2022.105410","journal-title":"React Funct Polym"},{"key":"4166_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.colsurfb.2018.07.025","volume":"171","author":"A Sargazi","year":"2018","unstructured":"Sargazi A, Shiri F, Keikha S, Majd MH (2018) Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells. Colloids Surf B Biointerfaces 171:150\u2013158. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.07.025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4166_CR42","doi-asserted-by":"publisher","first-page":"102426","DOI":"10.1016\/j.jddst.2021.102426","volume":"62","author":"A Shah","year":"2021","unstructured":"Shah A, Aftab S, Nisar J et al (2021) Nanocarriers for targeted drug delivery. J Drug Deliv Sci Technol 62:102426. https:\/\/doi.org\/10.1016\/j.jddst.2021.102426","journal-title":"J Drug Deliv Sci Technol"},{"key":"4166_CR43","doi-asserted-by":"publisher","first-page":"100484","DOI":"10.1016\/j.mtadv.2024.100484","volume":"22","author":"SD Shirsat","year":"2024","unstructured":"Shirsat SD, Londhe PV, Gaikwad AP et al (2024) Endosomal escape in magnetic nanostructures: recent advances and future perspectives. Mater Today Adv 22:100484. https:\/\/doi.org\/10.1016\/j.mtadv.2024.100484","journal-title":"Mater Today Adv"},{"key":"4166_CR44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.msec.2018.12.138","volume":"98","author":"A Sodagar Taleghani","year":"2019","unstructured":"Sodagar Taleghani A, Ebrahimnejad P, Heidarinasab A, Akbarzadeh A (2019) Sugar-conjugated dendritic mesoporous silica nanoparticles as pH-responsive nanocarriers for tumor targeting and controlled release of deferasirox. Mater Sci Eng C 98:358\u2013368. https:\/\/doi.org\/10.1016\/j.msec.2018.12.138","journal-title":"Mater Sci Eng C"},{"key":"4166_CR45","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ijbiomac.2022.09.037","volume":"221","author":"A Soltani","year":"2022","unstructured":"Soltani A, Faramarzi M, Farjadian F et al (2022) pH-responsive glycodendrimer as a new active targeting agent for doxorubicin delivery. Int J Biol Macromol 221:508\u2013522. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.09.037","journal-title":"Int J Biol Macromol"},{"key":"4166_CR46","doi-asserted-by":"publisher","first-page":"141874","DOI":"10.1016\/j.ijbiomac.2025.141874","volume":"307","author":"A Tiwari","year":"2025","unstructured":"Tiwari A, Yadav P, Shah AA et al (2025) Designing pegylated dextran sheathed doxorubicin loaded iron nanoparticles against premenopausal breast cancer. Int J Biol Macromol 307:141874. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141874","journal-title":"Int J Biol Macromol"},{"key":"4166_CR47","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bbrc.2022.08.023","volume":"627","author":"G Wu","year":"2022","unstructured":"Wu G, Li X, Zhan Y et al (2022) BID- and BAX-mediated mitochondrial pathway dominates A-1331852-induced apoptosis in senescent A549\u00a0cells. Biochem Biophys Res Commun 627:160\u2013167. https:\/\/doi.org\/10.1016\/j.bbrc.2022.08.023","journal-title":"Biochem Biophys Res Commun"},{"key":"4166_CR48","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1007\/s00210-023-02894-8","volume":"397","author":"EH Yousef","year":"2024","unstructured":"Yousef EH, El-Mesery ME, Habeeb MR, Eissa LA (2024) Diosgenin potentiates the anticancer effect of doxorubicin and volasertib via regulating polo-like kinase 1 and triggering apoptosis in hepatocellular carcinoma cells. Naunyn Schmiedebergs Arch Pharmacol 397:4883\u20134894. https:\/\/doi.org\/10.1007\/s00210-023-02894-8","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4166_CR49","doi-asserted-by":"publisher","first-page":"120872","DOI":"10.1016\/j.ijpharm.2021.120872","volume":"606","author":"S-J Yuan","year":"2021","unstructured":"Yuan S-J, Wang C, Xu H-Z et al (2021) Conjugation with nanodiamonds via hydrazone bond fundamentally alters intracellular distribution and activity of doxorubicin. Int J Pharm 606:120872. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120872","journal-title":"Int J Pharm"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04166-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04166-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04166-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:14:29Z","timestamp":1759983269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04166-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4166"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04166-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5466006\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}